Skip to main content
. Author manuscript; available in PMC: 2018 Jun 16.
Published in final edited form as: Cancer Res. 2017 May 18;77(16):4498–4505. doi: 10.1158/0008-5472.CAN-16-1944

Figure 1.

Figure 1

A) Lung adenocarcinoma samples with no, partial or near-complete MET exon 14 skipping and number of samples with wild type (wt) and mutant MET in each group. B) Single nucleotide variants and deletions seen near exon 14 in lung adenocarcinoma samples with mRNA evidence of exon 14 skipping.